Immunohistochemical Expression of E-cadherin in Invasive Duct Carcinoma of the Breast

Evaluation of Claudin-1 and Ki-67 in Different Molecular Subtypes of Breast Ductal Carcinoma: Immunohistochemical Study

THE RNA EXPRESSION LEVEL OF SURVIVIN, OCT 4 AND CYCLIN D1 GENES IN TRIPLE NEGATIVE AND NON-TRIPLE NEGATIVE BREAST CANCER

EVALUATION OF KI67 PREDICTIVE ROLE AND ITS DISCORDANCE BETWEEN PRETHERAPY BIOPSY AND POST THERAPY SURGICAL SPECIMEN IN BREAST CANCER PATIENTS RECEIVING NEOADJUVANT CHEMOTHERAPY.

Nestin as a Prognostic Marker in ductal carcinoma of the breast

Immunohistochemical expression of EGFR intriple-negative breast cancer and its correlationwith clinicopathological characteristics of these tumors

Ki 67 Expression in Molecular Sub types of Breast Cancer in Patients of Zagazig University Hospitals

Assessment of PI3KCA immunohistochemical expression and tumor infiltrating lymphocytes (CD4 and CD8) in invasive breast carcinoma and their relation to molecular subtypes

Immunohistochemical expression of programmed death-ligand 1 (PD-L1) in invasive duct carcinoma of the breast of no special type and correlation with patients' clinicopathological

An immunohistochemical study for evaluation of CYTOKERATIN 5/6 AND S100 expression in intraductal proliferative breast lesions and ductal carcinoma in situ